Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew F Teich

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
Journal of the American Academy of Dermatology|December 16, 2014
Resolution of urticarial vasculitis after treatment of neurocysticercosisSheila Shaigany, Ellen Dabela, Andrew F Teich, et al.
Journal of Alzheimer'S Disease : JAD|July 20, 2012
5-HT₄ receptor stimulation leads to soluble AβPPα production through MMP-9 upregulationGakuji Hashimoto, Mikako Sakurai, Andrew F Teich, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Basic Science and PathogenesisVivek Ruhela, Basilio Cieza, Richard Mayeux, et al.
Journal of Alzheimer'S Disease : JAD|March 12, 2016
PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic DiseaseAndrew F Teich, Mikako Sakurai, Mitesh Patel, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 11, 2015
Synaptic therapy in Alzheimer's disease: a CREB-centric approachAndrew F Teich, Russell E Nicholls, Daniela Puzzo, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2018
Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected DementiaLeonardo Tariciotti, Matthew Casadei, Lawrence S Honig, et al.
Neurology|February 10, 2017
<sup>11</sup>C-PBR28 PET detects translocator protein in a patient with astrocytoma and Alzheimer diseaseWilliam C Kreisl, Robin Lawrence, Emily Page, et al.
Journal of Medicinal Chemistry|July 12, 2012
Design and synthesis of neuroprotective methylthiazoles and modification as NO-chimeras for neurodegenerative therapyZhihui Qin, Jia Luo, Lawren VandeVrede, et al.
Acta Neuropathologica|November 28, 2024
Elevated expression of the retrotransposon LINE-1 drives Alzheimer's disease-associated microglial dysfunctionNainika Roy, Imdadul Haq, Jason C Ngo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 29, 2006
Synaptotagmin-2 is essential for survival and contributes to Ca2+ triggering of neurotransmitter release in central and neuromuscular synapsesZhiping P Pang, Ernestina Melicoff, Daniel Padgett, et al.
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Journal of the American Academy of Dermatology|December 16, 2014
Resolution of urticarial vasculitis after treatment of neurocysticercosisSheila Shaigany, Ellen Dabela, Andrew F Teich, et al.
Journal of Alzheimer'S Disease : JAD|July 20, 2012
5-HT₄ receptor stimulation leads to soluble AβPPα production through MMP-9 upregulationGakuji Hashimoto, Mikako Sakurai, Andrew F Teich, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Basic Science and PathogenesisVivek Ruhela, Basilio Cieza, Richard Mayeux, et al.
Journal of Alzheimer'S Disease : JAD|March 12, 2016
PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic DiseaseAndrew F Teich, Mikako Sakurai, Mitesh Patel, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 11, 2015
Synaptic therapy in Alzheimer's disease: a CREB-centric approachAndrew F Teich, Russell E Nicholls, Daniela Puzzo, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2018
Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected DementiaLeonardo Tariciotti, Matthew Casadei, Lawrence S Honig, et al.
Neurology|February 10, 2017
<sup>11</sup>C-PBR28 PET detects translocator protein in a patient with astrocytoma and Alzheimer diseaseWilliam C Kreisl, Robin Lawrence, Emily Page, et al.
Journal of Medicinal Chemistry|July 12, 2012
Design and synthesis of neuroprotective methylthiazoles and modification as NO-chimeras for neurodegenerative therapyZhihui Qin, Jia Luo, Lawren VandeVrede, et al.
Acta Neuropathologica|November 28, 2024
Elevated expression of the retrotransposon LINE-1 drives Alzheimer's disease-associated microglial dysfunctionNainika Roy, Imdadul Haq, Jason C Ngo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 29, 2006
Synaptotagmin-2 is essential for survival and contributes to Ca2+ triggering of neurotransmitter release in central and neuromuscular synapsesZhiping P Pang, Ernestina Melicoff, Daniel Padgett, et al.
Pageof 10